person

Fabio N.

Country
Italy
Department
Internal Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
458
Sites with multiple studies

Has run more than one trial at 458 of 820 partner sites.

Specializations

Cardiovascular Research

This investigator specializes in primary prevention of atherosclerotic cardiovascular disease (ASCVD), with particular focus on innovative therapeutic approaches for high-risk patients. Their research encompasses major adverse cardiovascular events prevention strategies.

  • Cardiovascular Risk Management
  • Preventive Cardiology
  • Atherosclerosis Prevention

Their work addresses critical aspects of cardiovascular health maintenance and disease prevention in at-risk populations.

Hepatology

The investigator conducts extensive research in liver diseases, particularly focusing on non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASH). Their work includes evaluation of therapeutic interventions for liver fibrosis and steatohepatitis.

  • NASH Treatment
  • Liver Fibrosis
  • Hepatic Disease Management

Their research aims to advance understanding and treatment of complex liver conditions.

Metabolic Disorders

The investigator specializes in treating metabolic conditions, with particular emphasis on severe hypertriglyceridemia. Their research explores therapeutic solutions for managing lipid disorders and metabolic dysfunctions.

  • Lipid Management
  • Triglyceride Reduction
  • Metabolic Disease Treatment

Their work focuses on developing effective treatments for patients with severe metabolic disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.